Revenue from operations was ₹7,827.26 crore during the quarter under review, up from ₹7,047.51 crore in the year-ago period, it said
Homegrown pharma major Lupin on Wednesday posted a 22.19 per cent decline in consolidated net profit to ₹1,155.30 crore in the September quarter, dragged down by an exceptional item.
The company had posted a net profit of ₹1,484.83 crore in the corresponding period of the previous fiscal year, it said in a regulatory filing to the exchanges.
Revenue from operations was ₹7,827.26 crore during the quarter under review, up from ₹7,047.51 crore in the year-ago period, it said.
Lupin's total expenses also rose to ₹6,374.46 crore during the quarter from ₹5,130.54 crore in the same period last year.